Refiye Yanardağ
- Biochemistry top 0.5%
- Phytochemicals and Antioxidant Activities 19
- Pharmacology top 0.5%
- Drug-Induced Hepatotoxicity and Protection 15
-
- Natural Antidiabetic Agents Studies 28
- Diet, Metabolism, and Disease 14
- Clinical Biochemistry top 1%
- Advanced Glycation End Products research 26
-
- Pharmacological Effects and Toxicity Studies 33
-
- Vanadium and Halogenation Chemistry 21
-
- Biochemical effects in animals 17
- Co-authors
- Şehnaz BolkentÖzlem SaçanSevim TunalıSema BolkentAyşe CanNuriye AkevNurten ÖzsoyÖmür Karabulut Bulan
- Partner nations
- TürkiyeNigeriaUnited Kingdom
In The Last Decade
Refiye Yanardağ
219 papers receiving 3.5k citations
Peers
Comparison fields: 5 of 127
- Biochemistry 523
- Pharmacology 438
- Complementary and alternative medicine 364
- Endocrinology, Diabetes and Metabolism 716
- Clinical Biochemistry 281
Countries citing papers authored by Refiye Yanardağ
This map shows the geographic impact of Refiye Yanardağ's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Refiye Yanardağ with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Refiye Yanardağ more than expected).
Fields of papers citing papers by Refiye Yanardağ
This network shows the impact of papers produced by Refiye Yanardağ. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Refiye Yanardağ. The network helps show where Refiye Yanardağ may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Refiye Yanardağ, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 1 | |
| 11 | 2022 | 0 | |
| 12 | 2021 | 6 | |
| 13 | 2021 | 4 | |
| 14 | 2021 | 1 | |
| 15 | 2021 | 2 | |
| 16 | 2020 | 8 | |
| 17 | 2020 | 3 | |
| 18 | 2020 | 2 | |
| 19 | 2020 | 4 | |
| 20 | 2015 | 17 |
About Refiye Yanardağ
Refiye Yanardağ is a scholar working on Clinical Biochemistry, Biochemistry and Pharmacology, having authored 237 papers that have together received 3.8k indexed citations. Recurring topics across this work include Pharmacological Effects and Toxicity Studies (33 papers), Natural Antidiabetic Agents Studies (28 papers), Advanced Glycation End Products research (26 papers), Vanadium and Halogenation Chemistry (21 papers), Phytochemicals and Antioxidant Activities (19 papers), Biochemical effects in animals (17 papers), Drug-Induced Hepatotoxicity and Protection (15 papers) and Diet, Metabolism, and Disease (14 papers). The work is most often cited by research in Biochemistry (523 citations), Pharmacology (438 citations) and Complementary and alternative medicine (364 citations). Refiye Yanardağ has collaborated with scholars based in Türkiye, Nigeria and United Kingdom. Frequent co-authors include Şehnaz Bolkent, Özlem Saçan, Sevim Tunalı, Sema Bolkent, Ayşe Can, Nuriye Akev, Nurten Özsoy, Ömür Karabulut Bulan, Meral Koyutürk and Bahar Bilgin Sökmen.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.